(S)-Azetidine-2-carbonitrile hemioxalate

Catalog No. :
ACHDYK950
CAS No. :
2068137-88-0
Molecular Formula :
C10H14N4O4
Molecular Weight :
254.25

IUPAC Name:(S)-azetidine-2-carbonitrile hemioxalate

(S)-Azetidine-2-carbonitrile hemioxalate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$227.00Login to see priceInquiryInquiry
250mg95%$301.00Login to see priceInquiryInquiry
500mg95%$567.00Login to see priceInquiryInquiry
1g95%$849.00Login to see priceInquiryInquiry
5g95%$2550.00Login to see priceInquiryInquiry
10g95%$4249.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-Azetidine-2-carbonitrile hemioxalate
IUPAC Name(S)-azetidine-2-carbonitrile hemioxalate
MDL No.MFCD30471585
Molecular FormulaC10H14N4O4
Molecular Weight254.25
SMILESN#C[C@H]1NCC1.N#C[C@H]2NCC2.O=C(O)C(O)=O
InChI KeyOODAFZBGMZZKNL-SCGRZTRASA-N
Synonym2068137-88-0 | bis((2S)-azetidine-2-carbonitrile) | oxalic acid | Bis (2S)-azetidine-2-carbonitrile oxalic acid | Bis((2s)-azetidine-2-carbonitrile), oxalic acid | Bis((2S)-azetidine-2-carbonitrile) oxalic acid | (2S)-azetidine-2-carbonitrile hemioxalate
CAS No.2068137-88-0
PubChem CID127263309

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACHDYK950 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRXSW930 route compound structure diagram
    ACRXSW930556835-05-3
  2. Then
  3. ACHDYK950 route product structure diagram
    ACHDYK9502068137-88-0
Inquiry

2. ACHDYK950 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHDYK950 route product structure diagram
    ACHDYK9502068137-88-0
Inquiry

Comments (0)